Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
The Journal of Nervous and Mental Disease March 4, 2014 Peter Gasser, Dominique Holstein, Yvonne Michel et al. 752 citations
A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases. Treatment included drug-free psychotherapy sessions supplemented by two LSD-assisted psychotherapy sessions 2 to 3 weeks apart. The participants received...
DOI: 10.1097/nmd.0000000000000113 (opens in new tab)
Lysergic acid diethylamide
Adverse effect
Crossover study
Placebo
+5